The testing was poor ( no over 55s), the marketing was poor implying it had a higher efficacy than the initial 62%,described as an 'intriguing' possibility ( not a scientific term). The 'apparently'poor effectiveness against the SA vaccine was not really it's fault but didn't help it's cause.
Despite all this it could be the vaccine most beneficial to the world.
We'll see.
very well described that mate, i think 'just my opinion' get the 60+ bracket and any others below who are at risk double vaccinated and its good to ease out of lockdown, the media putting pressure on the government is not helping with this the same media who were putting pressure on them to lock down,things are looking good,thanks for the postEngland hospital deaths
By region
96 Midlands, 79 South East, 69 London, 61 East. 56 North West. 55 NE & Yorkshire, 20 South West
By age group:
20 - 39 (2) 0.4%
40 - 59 (28) 6.4%
60 - 79 (193) 44.3%
80 PLUS (213) 48.9%
The under 60s lowest in a while but the gap between the two older age groups closest I can ever recall.
And yet again (5th time this last week or so after hardly ever before) the over 80s sub 50%
This is very clear now that the over 80s are not dying in the same proportion as they used to do.
I do think vaccination of that age group starting longest ago is reasonably clear as to one factor why.
We should now see this become more obvious and quite possibly that group to fall below the 60 - 79s as these are only now starting to become immunised in large numbers so their obvious vaccine impact in these figures will still be some weeks away yet.
UK vaccinations: 544,603 1st doses delivered yesterday, compared to 494,163 on the same day last week
Cumulative 1st doses: just over 14.556 million
Brilliant!!!
The 15 million target by the 15th will have been achieved when today's figures are announced tomorrow. Incredible effort by everyone involved.
Disagree on testing being poor.
Oxford Uni initially ran the tests on under 65's as they were unsure on the safety at the start, Pfizer and Moderna went with older groups straight off the bat. It was an ethical decision, AZ said they would have run it on older to start with but Oxford were in charge.
Once proved safe they added older groups and worked out their antibody response compared to those in the younger cohorts and it was similar.
The initial findings were to get emergency approval, there are on going clinical trials in the US which will provide more data on the over 65's.
They could have waited for the US results to come in, but why wait unless you want a stagnant roll out like the EU?
On it being intriguing I'd say it was not far off the correct term, as when they got more data it turns out it wasn't the 0.5 then full dose regimen that improved efficacy, it was the spacing between doses.
And with the South African variant the Pfizer and J&J vaccines have been hailed for their T Cell response and protection against "severe disease", where as the AZ vaccines been put down for not protecting against mild and moderate disease when it highly likely still does the things Pfizer and J&J are being lauded for.
Quite a few on here saying they were vaccinated today or yesterday.1st jab today. Very quick and smooth process
It's understandable but I think there's possibly some confusion about the target.Brilliant!!!
The 15 million target by the 15th will have been achieved when today's figures are announced tomorrow. Incredible effort by everyone involved.